Bill

Bill > HB382


GA HB382

GA HB382
Controlled substances; Schedule I; psilocybin; revise a provision


summary

Introduced
02/11/2025
In Committee
03/09/2026
Crossed Over
03/06/2026
Passed
Dead

Introduced Session

2025-2026 Regular Session

Bill Summary

AN ACT To amend Code Section 16-13-25 of the Official Code of Georgia Annotated, relating to Schedule I controlled substances, so as to revise a provision relating to certain substances; to amend Chapter 4 of Title 26 of the Official Code of Georgia Annotated, relating to pharmacists and pharmacies, so as to modify the supervisory responsibilities of pharmacists; to allow pharmacy technicians to perform certain technical functions from a remote location; to provide for certain supervisory ratios; to provide for pharmacy interns and externs; to provide for definitions; to provide for the removal of the requirement that the State Board of Pharmacy may only require wholesale drug distributors to accept the return of drugs essential to healthcare treatment if such drugs have an expiration date that is less than one year from the date such drug is manufactured; to provide for a short title; to provide for construction; to provide for effectiveness contingencies; to provide for related matters; to repeal conflicting laws; and for other purposes.

AI Summary

This bill, titled the "Prescription Drug Security, Supervision, and Return Act," makes several changes to Georgia law, primarily concerning controlled substances and pharmacy operations. It revises the definition of Schedule I controlled substances to exclude specific forms of lysergic acid diethylamide (LSD) and psilocybin if they are approved by the federal Food and Drug Administration (FDA) and scheduled by the U.S. Drug Enforcement Administration (DEA) under federal law. The bill also modifies the responsibilities of pharmacists and pharmacy technicians, allowing technicians to perform certain technical functions remotely and establishing new supervisory ratios, including a pharmacist to technician ratio of one to four within the licensed pharmacy area, with remote technicians not counted towards this ratio. Additionally, it removes a previous restriction on the State Board of Pharmacy requiring wholesale drug distributors to accept the return of drugs essential to healthcare treatment only if their expiration date was less than one year from manufacturing, now allowing the board to exempt such drugs without that specific expiration date limitation. The effectiveness of the changes related to LSD and psilocybin is contingent on federal approval and scheduling of these specific drug forms.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Senate Read and Referred (on 03/09/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...